IRCT20200505047318N1CompletedPhase 3
Investigation of the effect of Finasterid on the prognosis in the hospitalized over 50 years male patients with COVID-19 pneumonia
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50 years to no limit (—)
- Sex
- Male
Inclusion Criteria
- •having covid-19
- •age>50 years
- •hospitalization
Exclusion Criteria
- •use finasterid before covid-19
- •neurologic disease
- •psychiatric disease
Investigators
Similar Trials
Recruiting
Phase 3
The effect of finasteride in the prevention of bladder tumor recurrenceIRCT20200608047702N1Tabriz University of Medical Sciences124
Recruiting
Phase 2
Effect of Finasteride gel in the treatment of acneAcne.AcneIRCT20160318027097N8Tabriz University of Medical Sciences48
Completed
Phase 1
Finasteride effect as a treatment for spontaneous retinal edemaCentral Serous Chorioretinopathy.Separation of retinal layersIRCT2013083114530N1Shahid Sadoughi University of Medical Science30
Recruiting
Phase 3
Comparative efficacy study of topical finasteride in androgenic alopeciaIRCT20191203045592N2Esfahan University of Medical Sciences40
Active, not recruiting
Not Applicable
Open-label study on the use of Finasteride in prolonged treatment (4 years) of tics in Tourette's disease and Parkinson's disease in the pounding - FINTOURPARKSyndrome Gilles de la Tourette's disease Parkinosn PoundingMedDRA version: 14.1Level: LLTClassification code 10013113Term: Disease Parkinson'sSystem Organ Class: 10029205 - Nervous system disordersEUCTR2011-000612-26-ITAZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI